This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Insider Trading Alert - Monsanto Company And 3 Others Traded By Insiders

Monday, July 8, 2013, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.15 to $10,873,958.42.

Highlighted Stocks Traded by Insiders:

Monsanto Company (MON) - FREE Research Report

Grant Hugh who is Chairman & CEO at MONSANTO CO-NEW bought 166,745 shares at $32.58 per share for a total value of $3,909,752.00 on July 3, 2013. Following this transaction, the Chairman & CEO owned 507,627 shares meaning that the stake was boosted by 39.62% with the 166,745 share acquisition.

Mizell Steven who is Exec. VP Human Resources at MONSANTO CO-NEW bought 78,976 shares at $74.39 per share for a total value of $6,886,467.65 on July 1, 2013. Following this transaction, the Exec. VP Human Resources owned 219,304 shares meaning that the stake was boosted by 36.85% with the 78,976 share acquisition.

The shares most recently traded at $100.53, up $1.34, or 1.35% since the insider transactions. Historical insider transactions for Monsanto Company go as follows:

  • 12-Week # shares sold: 160
  • 24-Week # shares sold: 30,160

The average volume for Monsanto Company has been 2.7 million shares per day over the past 30 days. Monsanto Company has a market cap of $52.6 billion and is part of the basic materials sector and chemicals industry. Shares are up 4.8% year to date as of the close of trading on Monday.

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The stock currently has a dividend yield of 1.52%. The company has a P/E ratio of 21.2. Currently there are 11 analysts that rate Monsanto Company a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MON - FREE

TheStreet Quant Ratings rates Monsanto Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Monsanto Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs